Acquired cystic kidney disease and renal cell cancer after transplantation: Time to rethink screening?

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 4, 2007, Pages 621-622

  Scandling, John D ^a  

^a Adult Kidney and Pancreas Transplant Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; KIDNEY CARCINOMA; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; KIDNEY TUMOR; NOTE;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY DISEASES, CYSTIC; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION;

EID: 34548848552     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02000507     Document Type: Editorial

References (17)

1. Gehrig JJ Jr, Gottheiner TI, Swenson RS: Acquired cystic disease of the end-stage kidney. Am J Med 79: 609-620, 1985
2. Dunnill MS, Millard PR, Oliver D: Acquired cystic disease of the kidneys: A hazard of long-term intermittent maintenance haemodialysis. J Clin Pathol 30: 868-877, 1977
3. Chapman AB, Rahbari-Oskoui FF, Bennett WM: Acquired cystic disease of the kidney in adults. UpToDate version 15.1. Available online: http://www.uptodate.com. Accessed May 10, 2007
4. Lien YH, Hunt KR, Siskind MS, Zukoski C: Association of cyclosporin A with acquired cystic kidney disease of the native kidneys in renal transplant recipients. Kidney Int 44: 613-616, 1993
5. Oya M, Mikami S, Miznno R, Marumo K, Mukai M, Murai M: C-jun activation in acquired cystic kidney disease and renal cell carcinoma. J Urol 174: 726-730, 2005
6. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C: Cancer after kidney transplantation in the United States. Am J Transplant 4: 905-913, 2004
7. Sarasin FP, Wong JB, Levey AS, Meyer KB: Screening for acquired cystic kidney disease: A decision analytic perspective. Kidney Int 48: 207-219, 1995
8. Kasiske BL, Cangro CB, Hariharan S, Hricik DE, Kerman RH, Roth D, Rush DN, Vazquez MA, Weir MR; for the American Society of Transplantation: The evaluation of renal transplant candidates: Clinical practice guidelines. Am J Transplant 1[Suppl 2]: 3-95, 2001
9. EBPG Expert Group on Renal Transplantation, European Renal Association-European Dialysis and Transplant Association: Evaluation, selection and preparation of the potential transplant recipient. Nephrol Dial Transplant 15[Suppl 7]: 3-38, 2000
10. Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, Roth D, Scandling JD Jr, Singer GS; for the American Society of Transplantation: Recommendations for the outpatient surveillance of renal transplant recipients. J Am Soc Nephrol 11[Suppl 15]: S1-S86, 2000
11. EBPG Expert Group on Renal Transplantation, European Renal Association-European Dialysis and Transplant Association: Long-term management of the transplant recipient. Nephrol Dial Transplant 17[Suppl 4]: 3-67, 2002
12. Schwarz A, Vatandaslar S, Merkel S, Hailer H: Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol 2: 750-756, 2007
13. Israel GM, Bosniak MA: An update of the Bosniak renal cyst classification system. Urology 66: 484-488, 2005
14. Kliem V, Kolditz M, Behrend M, Ehlerding G, Pichlmayr R, Koch KM, Brunkhorst R: Risk of renal cell carcinoma after kidney transplantation. Clin Transplant 11: 255-258, 1997
15. US Renal Data System: USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Vol 1, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006, p 136
16. Dantal J, Pohanka E: Malignancies in renal transplantation: An unmet medical need. Nephrol Dial Transplant 22[Suppl 1]: i4-i10, 2007
17. Campistol JM, Albanell J, Ares W, Boletis I, Dantal J, de Fijter JW, Mortensen SA, Neumayer H-H, Oyen O, Pascual J, Pohanka E, Schena FP, Seron D, Sparacino V, Chapman JR: Use of proliferation signal inhibitors in the management of post-transplant malignancies: Clinical guidance. Nephrol Dial Transplant 22[Suppl 1]: i36-i41, 2007